Floatz logo

Calcium folinate pentahydrate

Mucinous Adenocarcinoma of the Colon

University of Southern CaliforniaSmall moleculePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mucinous Adenocarcinoma of the Colon cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
University of Southern California
Phase 3BBB
Eloxatin
John Hays
Phase 3BB
Irinotecan
Fox Chase Cancer Center
Phase 3BB
Cetuximab
National Cancer Institute (NCI)
Phase 2BB
(+)-VINCRISTINE
University of California, Davis
Phase 2B

View all 23 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →